Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Reinhold, U; Seiter, S; Ugurel, S; Tilgen, W.
Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.
J Am Acad Dermatol. 1999; 41(2 Pt 1):207-208 Doi: 10.1016/S0190-9622(99)70050-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Ugurel-Becker Selma
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Background: Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. Objective: We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic progressive pigmented purpura (PPP). Methods: In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. Results: At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Conclusion: Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP! Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Oral -
Adult -
Aged -
Antioxidants - administration and dosage Antioxidants - therapeutic use
Ascorbic Acid - administration and dosage Ascorbic Acid - therapeutic use
Child -
Female -
Flavonoids - administration and dosage Flavonoids - therapeutic use
Humans -
Pigmentation Disorders - drug therapy
Pilot Projects -
Purpura - drug therapy
Rutin - administration and dosage Rutin - analogs and derivatives Rutin - therapeutic use

© Med Uni Graz Impressum